Document Detail


Noncathartic CT colonography: Image quality assessment and performance and in a screening cohort.
MedLine Citation:
PMID:  24059367     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Cathartic bowel preparation is a major barrier for colorectal cancer screening. We examined noncathartic CT colonography (CTC) quality and performance using four similar bowel-tagging regimens in an asymptomatic screening cohort.
SUBJECTS AND METHODS: This prospective study included 564 asymptomatic subjects who underwent noncathartic CTC without dietary modification but with 21 g of barium with or without iodinated oral contrast material (four regimens). The quality of tagging with oral agents was evaluated. A gastrointestinal radiologist evaluated examinations using primary 2D search supplemented by electronic cleansing (EC) and 3D problem solving. Results were compared with complete colonoscopy findings after bowel purgation and with retrospective unblinded evaluation in 556 of the 564 (99%) subjects.
RESULTS: Of the 556 subjects, 7% (37/556) and 3% (16/556) of patients had 52 and 20 adenomatous polyps ≥ 6 and ≥ 10 mm, respectively. The addition of iodine significantly improved the percentage of labeled stool (p ≤ 0.0002) and specificity (80% vs 89-93%, respectively; p = 0.046). The overall sensitivity of noncathartic CTC for adenomatous polyps ≥ 6 mm was 76% (28/37; 95% CI, 59-88%), which is similar to the sensitivity of the iodinated regimens with most patients (sensitivity: 231 patients, 74% [14/19; 95% CI, 49-91%]; 229 patients, 80% [12/15; 95% CI, 52-96%]). The negative predictive value was 98% (481/490), and the lone cancer was detected (0.2%, 1/556). EC was thought to improve conspicuity of 10 of 21 visible polyps ≥ 10 mm.
CONCLUSION: In this prospective study of asymptomatic subjects, the per-patient sensitivity of noncathartic CTC for detecting adenomas ≥ 6 mm was approximately 76%. Inclusion of oral iodine contrast material improves examination specificity and the percentage of labeled stool. EC may improve polyp conspicuity.
Authors:
Joel G Fletcher; Alvin C Silva; Jeff L Fidler; Joseph G Cernigliaro; Armando Manduca; Paul J Limburg; Lynn A Wilson; Trudy A Engelby; Garrett Spencer; W Scott Harmsen; Jay Mandrekar; C Daniel Johnson
Related Documents :
7668497 - Necrosectomy and postoperative local lavage in necrotizing pancreatitis.
18415757 - Risk factors for recurrent acute alcohol-associated pancreatitis: a prospective analysis.
23563307 - Telbivudine versus entecavir for nucleos(t)ide-naive hbeag-positive chronic hepatitis b...
24521307 - Anal fistula plug: a prospective evaluation of success, continence, and quality of life...
1843987 - A clinical study of ferric sulfate as a pulpotomy agent in primary teeth.
16241177 - The effect of nasopharyngoscopic biofeedback in patients with cleft palate and velophar...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  AJR. American journal of roentgenology     Volume:  201     ISSN:  1546-3141     ISO Abbreviation:  AJR Am J Roentgenol     Publication Date:  2013 Oct 
Date Detail:
Created Date:  2013-09-24     Completed Date:  2013-11-14     Revised Date:  2014-02-12    
Medline Journal Info:
Nlm Unique ID:  7708173     Medline TA:  AJR Am J Roentgenol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  787-94     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Barium Sulfate / diagnostic use*
Cathartics / diagnostic use
Cohort Studies
Colonic Polyps / epidemiology*,  radiography*
Colonography, Computed Tomographic / statistics & numerical data*
Contrast Media
Enema
Female
Humans
Image Enhancement / methods
Image Interpretation, Computer-Assisted / methods*
Male
Mass Screening / statistics & numerical data*
Middle Aged
Prevalence
Reproducibility of Results
Risk Assessment
Sensitivity and Specificity
United States / epidemiology
Grant Support
ID/Acronym/Agency:
R01 CA75333/CA/NCI NIH HHS; UL1RR024150/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Cathartics; 0/Contrast Media; 25BB7EKE2E/Barium Sulfate
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Imaging features of carcinoid tumors of the gastrointestinal tract.
Next Document:  Hepatocellular carcinoma: perfusion quantification with dynamic contrast-enhanced MRI.